ITERUM THERAPEUTICS

Iterum Therapeutics plc is a clinical-stage pharmaceutical company dedicated to developing significantly differentiated anti-infectives aimed at combating the global crisis of multi-drug resistant (MDR) pathogens... Iterum Therapeutics plc: Headquartered in Dublin, Ireland, we are dedicated to developing significantly differentiated anti-infectives aimed at combating the global crisis of multi-drug resistant (MDR) pathogens to significantly improve the lives of people affected by serious and life-threatening diseases around the world. In October 2024, the US Food and Drug Administration (FDA) approved ORLYNVAH TM, the first and only approved oral penem, for the treatment of uncomplicated urinary tract infections (uUTI) in patients who have limited or no alternative oral antibiotic treatments.

Also known as: Iterum, Iterum Therapeutics Limited, Iterum Therapeutics plc

Registration numbers: 563531 (W)

Primary location: Ireland